Skip to main content
. 2014 Dec 19;5:499. doi: 10.3389/fphys.2014.00499

Figure 2.

Figure 2

The TPR-response to tyramine in WKY and SHR, without and after acute AdrX. The rats were pre-treated with the β3AR antagonist SR59230A or agonist BRL37344 as indicated by symbol legends. The TPR-results in the SR59230A-treated groups are from Berg et al. (2010). *P ≤ 0.025 after curve evaluation (please see Methods).